Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. in September, 2020 for $999,883.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA254613-01 | Phase II | 999,883 | September 7, 2020 | |||||||
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. in September, 2020 for $997,658.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA250872-01A1 | Phase II | 997,658 | September 15, 2020 | |||||||
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. in September, 2019 for $958,108.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA203430-02A1 | Phase II | 958,108 | September 20, 2019 | |||||||
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. in August, 2022 for $990,225.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA268314-01A1 | Phase II | 990,225 | August 4, 2022 | |||||||
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. in July, 2022 for $976,668.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA232954-02A1 | Phase II | 976,668 | July 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Viewpoint Molecular Targeting, Inc. in June, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232954-01A1 | Phase I | 300,000 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Viewpoint Molecular Targeting, Inc. in January, 2016 for $348,530.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA203430-01 | Phase I | 348,530 | January 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Viewpoint Molecular Targeting, Inc. in May, 2015 for $149,842.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA195925-01 | Phase I | 149,842 | May 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Viewpoint Molecular Targeting, Inc. for $1,944,651.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201700036C-0-0-0 | Phase II | 1,944,651 | ||||||||
A SBIR Phase I contract was awarded to Viewpoint Molecular Targeting, Inc. for $298,184.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201500069C-0-0-0 | Phase I | 298,184 |